F H Wang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

F H Wang

Showing results (71-80 of 72) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 72 results.

Oncogene|September 29, 2015

INPP4B is an oncogenic regulator in human colon cancerS T Guo, M N Chi, R H Yang, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2019

Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432F Wang, X L Wei, F H Wang, et al.

Pageof 8

Search research articles

Showing results (71-80 of 72) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 72 results.

Oncogene|September 29, 2015

INPP4B is an oncogenic regulator in human colon cancerS T Guo, M N Chi, R H Yang, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2019

Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432F Wang, X L Wei, F H Wang, et al.

Pageof 8